The Food and Drug Administration should consider some sort of measuring stick when assessing a vendor’s cybersecurity culture to determine if it qualifies for the agency’s proposed fast-path program for premarket approval of “software as a medical device” products, some industry stakeholders say.

Source: Click here

Share this article

Facebook Comments